Create a Free Account
or
BCAX Bicara Therapeutics Inc.
Nasdaq www.bicara.com
$ 14.81 $ 0.52 (3.65 %)
Friday, 14-Nov-2025 15:55:00 EST
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| 1 | 11-10-2025 | 09-30-2025 | 10-Q | |
| 2 | 08-12-2025 | 06-30-2025 | 10-Q | |
| 3 | 05-13-2025 | 03-31-2025 | 10-Q | |
| 4 | 03-27-2025 | 12-31-2024 | 10-K | |
| 5 | 11-12-2024 | 09-30-2024 | 10-Q |
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Wells Fargo analyst Eva Fortea Verdejo maintains Bicara Therapeutics (NASDAQ:BCAX) with a Equal-Weight and raises the price ...
Bicara Therapeutics (NASDAQ:BCAX) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of...
The SPDR S&P Biotech ETF (ARCA:XBI) is up more than 40% over the past six months and is on the verge of breaking out. Here...
https://www.sec.gov/Archives/edgar/data/2023658/000119312525230307/d54249ds3.htm
HC Wainwright & Co. analyst Robert Burns maintains Bicara Therapeutics (NASDAQ:BCAX) with a Buy and lowers the price tar...
Piper Sandler analyst Kelsey Goodwin initiates coverage on Bicara Therapeutics (NASDAQ:BCAX) with a Overweight rating and an...
Bicara Therapeutics (NASDAQ:BCAX) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $...
